CHUM acquires linear accelerators, software from Elekta

MONTREAL – Elekta has signed an agreement to provide the Centre hospitalier de l’Universite de Montreal (CHUM) with advanced linear accelerators and software. The order, resulting from a competitive tender process, is valued at more than US$20 million.

The CHUM was formed through the merger of three teaching hospitals, including the 372-year old Hotel-Dieu Hospital. It is one of the largest hospitals in Canada and a leading academic center in the province of Quebec.

To increase the efficiency of its new, integrated cancer center, the CHUM has chosen Elekta’s MOSAIQ oncology information system to manage the complete spectrum of oncology treatments in a single patient record. The record is accessible by 17 multi-disciplinary teams across multiple locations.

The partnership agreement also includes Elekta Infinity linear accelerators with Agility multileaf collimators. At the core of a new radiotherapy treatment platform, this sophisticated technology will offer CHUM’s clinicians superior dose conformance and treatment speed as well as high-resolution beam shaping. For patients, it means safer, faster treatment with less risk of damage to healthy tissue.

Dr. David Roberge (pictured), Head of Radiation Oncology at CHUM, says: “We chose Elekta, not simply for the advanced capabilities of its linear accelerators, but because of our shared vision for improving cancer management. Together, we will better integrate our cancer care activities – whether it be clinical research, screening, surgery, systemic therapy, radiation, survivorship or palliative care. MOSAIQ will ensure that patients have the most efficient management options available.”

Jay Hoey, Executive Vice President of Region North America, says: “This is another example of how Elekta is aligning with comprehensive cancer programs to lead the future of cancer care together. We hope to establish MOSAIQ as the primary electronic medical record solution for cancer care across the province, thereby enhancing the experience for cancer patients and providers.”

Michael Power, Vice President and Managing Partner for Elekta Canada, says: “Elekta is already well positioned in Quebec, and with this strategically important partnership, our commitment to the region will be even stronger.”

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives. For more information, please visit www.elekta.com.